Colgate-Palmolive Company $CL Shares Sold by Hazlett Burt & Watson Inc.

Hazlett Burt & Watson Inc. lowered its position in shares of Colgate-Palmolive Company (NYSE:CL) by 1.7% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 9,619 shares of the company’s stock after selling 163 shares during the quarter. Hazlett Burt & Watson Inc.’s holdings in Colgate-Palmolive were worth $874,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of CL. Price T Rowe Associates Inc. MD grew its holdings in shares of Colgate-Palmolive by 18.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock worth $3,186,651,000 after purchasing an additional 5,269,140 shares during the period. Nuveen LLC purchased a new stake in shares of Colgate-Palmolive during the 1st quarter worth about $217,593,000. Goldman Sachs Group Inc. grew its holdings in shares of Colgate-Palmolive by 34.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock worth $747,762,000 after purchasing an additional 2,045,191 shares during the period. Diamond Hill Capital Management Inc. grew its holdings in shares of Colgate-Palmolive by 45.0% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock worth $521,250,000 after purchasing an additional 1,727,105 shares during the period. Finally, Alliancebernstein L.P. grew its holdings in shares of Colgate-Palmolive by 60.5% during the 1st quarter. Alliancebernstein L.P. now owns 2,336,783 shares of the company’s stock worth $218,957,000 after purchasing an additional 880,527 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. The Goldman Sachs Group decreased their target price on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a report on Thursday, October 2nd. Bank of America decreased their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. UBS Group decreased their price target on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating for the company in a report on Wednesday. Barclays decreased their price target on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Finally, JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating for the company in a report on Friday. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $92.21.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $77.99 on Monday. The stock has a market cap of $63.03 billion, a P/E ratio of 21.91, a price-to-earnings-growth ratio of 4.29 and a beta of 0.34. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock has a 50 day moving average of $82.56 and a 200-day moving average of $87.84. Colgate-Palmolive Company has a 52 week low of $77.09 and a 52 week high of $102.61.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business’s revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 EPS. On average, analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is 58.43%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.